参考文献/References:
[1]中国糖尿病防控专家共识专家组.中国糖尿病防控专家共识[J].中华预防医学杂志,2017,51(1):12.
[2]中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中国医学前沿杂志,2011,3(5):42-93.
[3]Eapen DJ,Manocha P,Patel RS,et al.Aggregate Risk Score Based on Markers of Inflammation,Cell Stress,and Coagulation is an Independent Predictor of Adverse Cardiovascular Outcomes[J].J Am Coll Cardiol,2013,62(4):329-337.
[4]中华医学会糖尿病分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,6(7):447-498.
[5]Anna C Roberts,Karen E Porter.Cellular and molecular mechanisms of endothelial dysfunction in diabetes[J].Diab Vasc Dis Res,2013,10(6):472-482.
[6]Krzych LJ,Bochenek A.Blood pressure variability:Epidemiological and issues[J].Cardiol J,2013,20(2):112-120.
[7]Altiparmak IH,Erkus ME,Gunebakmaz O.Oxidative stress is associated with not only coronary artery disease on statin therapy but also diabetes mellitus and hypertension[J].Indian Heart J,2016,68(2):194-195.
[8]Tibaut M,Petrovic D.Oxidative stress genes,antioxidants and coronary artery disease in type 2 diabetes mellitus[J].Cardiovasc Hematol Agents Med Chem,2016,14(1):23-38.
[9]Rask-Madsen C,King GL.Mechanisms of disease:endothelial dysfunction in insulin resistance and diabetes[J].Nat Clin Pract Endocrinol Metab,2015,11(2):46-56.
[10]Zaccardi F,Rocca B,Pitocco D,et al.Platelet mean volume,distribution width,and count in type 2 diabetes,impaired fasting glucose,and metabolic syndrome:A meta-analysis[J].Diabetes Metab Res Rev,2015,31(4):402-410.[11]Giuseppe Maiolino,Valeria Bisogni,Giacomo Rossitto,et al.Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications[J].World J Cardiol,2015,7(10):609-620.
[12]He S,Chousterman BG,Fenn A,et al.Lp-PLA2 antagonizes left ventricular healing after myocardial infarction by impairing the appearance of reparative macrophages[J].Circ Heart Fail,2015,8(5):980-987.
[13]Tellis CC,Tselepis AD.Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2(Lp-PLA2)Bound to LDL and HDL[J].Curr Pharm Des,2014(40):6256-6269.
[14]Kim M,Jeung SR,Jeong TS,et al.Replacing with whole grains and legumes reduces lipoprotein-associated phospholipase A2(Lp-PLA2)activities in plasma and peripheral blood mononuclear cells in patients with prediabetes or newly diagnosed type 2 diabetes[J].J Lipid Res,2014,55(4):1762-1771.
[15]Archana Buch,Supreet Kaur,Ambuj Jain,et al.Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients[J].J Lab Physicians,2017,9(2):84-88.
[16]Cheraghi A,Mahmoudi M,Jafarian K,et al.Comparison of Serum LP-PLA2 Level and some Nutritional Factors between Well-Controlled and Poorly-Controlled Diabetic Patients[J].Acta Med Iran,2015,53(11):690-696.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(05):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(05):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(05):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[5]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(05):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[6]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Journal of Medical Information,2022,35(05):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[7]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Journal of Medical Information,2022,35(05):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[8]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Journal of Medical Information,2022,35(05):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[9]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(05):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[10]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(05):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]